Explore Watchlists Pricing

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Balance sheet

Market cap

$34.6B

P/E ratio

24.9x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	1,248	1,096	2,879	1,038	2,226	6,946	988	963	1,782	1,975	2,177	2,198	2,834	3,227	3,300	3,556
Total cash & short-term investments	1,248	1,096	2,879	1,038	2,226	6,946	988	963	1,782	1,975	2,177	2,198	2,834	3,227	3,300	3,556
Accounts receivable, net	5,476	6,213	5,572	5,338	5,408	5,350	7,523	7,128	5,822	5,676	4,581	4,529	3,696	3,408	3,059	3,709
Inventories	3,866	5,012	5,502	5,053	4,371	3,966	4,954	4,924	4,731	4,422	4,403	3,818	3,833	4,021	3,007	3,179
Total current assets	12,042	14,453	16,355	13,720	14,396	18,398	16,961	15,382	13,794	13,464	13,005	12,573	12,051	12,485	12,552	13,946
Property, plant and equipment, net	4,357	5,947	6,315	6,635	6,535	6,544	8,073	7,673	6,868	6,436	6,296	5,982	5,739	5,750	4,581	4,080
Total assets	38,152	50,142	50,609	47,508	46,420	54,258	92,890	70,615	60,683	57,470	50,640	47,666	44,006	43,479	39,326	40,748
Long-term debt, current	-	-	-	-	-	-	-	-	-	1,831	2,674	1,403	2,086	1,649	1,758	1,798
Total current liabilities	9,694	13,847	12,888	11,965	12,289	13,005	18,519	17,921	14,322	13,674	13,164	11,027	11,469	12,247	12,796	13,456
Total non-current liabilities	6,456	13,952	14,854	12,907	10,776	11,326	39,378	33,949	30,567	28,733	26,414	25,395	23,846	23,106	20,809	19,379
Total liabilities	16,150	27,799	27,742	24,872	23,065	24,331	57,897	51,870	44,889	42,407	39,579	36,422	35,315	35,353	33,606	32,834
Retained earnings	9,325	11,284	12,346	12,535	14,436	14,851	13,607	-3,803	-5,958	-6,956	-10,946	-10,529	-12,882	-13,534	-15,173	-13,762
Stockholders' equity	22,002	22,343	22,867	22,636	23,355	29,927	34,993	18,745	15,794	15,063	11,061	11,244	8,691	8,126	5,380	7,914